Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients

Figure 5

First three days after operative serum AST peak according to graft large droplet (Ld-MaS) and small-droplet (Sd-MaS) macrovesicular steatosis distribution in recipients with HCV unrelated (a) and related (b) liver disease.

(a)

(b)